Anagh A. Sahasrabuddhe

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

Mark J. Kiel, Thirunavukkarasu Velusamy, Delphine Rolland et al. · Blood · 2014 · 255 citations · Full text

Life Sciences, Genetics, Oncology +14

Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome

Mark J. Kiel, Anagh A. Sahasrabuddhe, Delphine Rolland et al. · Nature Communications · 2015 · 202 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells

Manjari Dimri, Prashant V. Bommi, Anagh A. Sahasrabuddhe et al. · Carcinogenesis · 2009 · 128 citations · Full text

Medicine, Molecular Biology, Oncology +15

A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders

Thirunavukkarasu Velusamy, Mark J. Kiel, Anagh A. Sahasrabuddhe et al. · Blood · 2014 · 100 citations · Full text

Medicine, Dermatology, Molecular Genetics +12

Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation

Anagh A. Sahasrabuddhe, Xinyi Chen, Fung‐Lung Chung et al. · Oncogene · 2014 · 93 citations

Life Sciences, Genetics, Molecular Biology +8